Determination of Current Knowledge

[1]  Roberto Gobetto,et al.  Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges , 2017, Advanced drug delivery reviews.

[2]  F. Główka,et al.  Enantioselective CE method for pharmacokinetic studies on ibuprofen and its chiral metabolites with reference to genetic polymorphism , 2007, Electrophoresis.

[3]  O. Baud,et al.  Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants? , 2010, PloS one.

[4]  S. Zeng,et al.  Influence of CYP2C8 polymorphisms on the hydroxylation metabolism of paclitaxel, repaglinide and ibuprofen enantiomers in vitro , 2013, Biopharmaceutics & drug disposition.

[5]  D. Ochoa,et al.  Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers. , 2015, Pharmacogenomics.

[6]  Yan He,et al.  Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts. , 2017, Journal of pharmaceutical sciences.

[7]  Ahmad B. Albadarin,et al.  Spray drying ternary amorphous solid dispersions of ibuprofen – An investigation into critical formulation and processing parameters , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  J. Mitchell,et al.  Effects of crystal habit on the sticking propensity of ibuprofen-A case study. , 2017, International journal of pharmaceutics.

[9]  Uwe Dulleck,et al.  Mapping the global influence of published research on industry and innovation , 2018, Nature Biotechnology.

[10]  F. L. Soares,et al.  Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals. , 2014, Journal of pharmaceutical and biomedical analysis.

[11]  Ann Newman,et al.  Solid form changes during drug development: good, bad, and ugly case studies , 2016, AAPS Open.

[12]  A. Kwade,et al.  Formation of long‐term stable amorphous ibuprofen nanoparticles via antisolvent melt precipitation (AMP) , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  N. Rasenack,et al.  Ibuprofen crystals with optimized properties. , 2002, International journal of pharmaceutics.

[14]  E. T. White,et al.  Preparation of Ibuprofen Microparticles by Antisolvent Precipitation Crystallization Technique: Characterization, Formulation, and In Vitro Performance. , 2018, Journal of pharmaceutical sciences.

[15]  A. Johari,et al.  Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release. , 2014, Journal of colloid and interface science.

[16]  John D. Westbrook,et al.  The Nucleic Acid Database: new features and capabilities , 2013, Nucleic Acids Res..

[17]  E. García-Martín,et al.  The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects. , 2005, British journal of clinical pharmacology.

[18]  Z. Nagy,et al.  Real-time monitoring of the mechanism of ibuprofen-cationic dextran crystanule formation using crystallization process informatics system (CryPRINS). , 2016, International journal of pharmaceutics.

[19]  Ivan Bilić,et al.  How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity / Kako polimorfizmi gena citokroma P450 utječu na metabolizam i toksičnost ibuprofena i diklofenaka , 2016, Arhiv za higijenu rada i toksikologiju.

[20]  C Saal,et al.  Pharmaceutical salts: a summary on doses of salt formers from the Orange Book. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  Ewa Skorupska,et al.  Solid State NMR Characterization of Ibuprofen:Nicotinamide Cocrystals and New Idea for Controlling Release of Drugs Embedded into Mesoporous Silica Particles. , 2017, Molecular pharmaceutics.